Crizotinib-induced hyperlipidemia in advanced lung adenocarcinoma: A case report and literature review. [PDF]
Ren S, Chen R.
europepmc +1 more source
Genomic profiling of a DICER1-wildtype thyroblastoma reveals AGK-BRAF fusion, EIF1AX duplication, and TERT promoter mutations: integrated genomic and pathway analysis. [PDF]
Gualandi A +11 more
europepmc +1 more source
Autophagy in Ovarian Cancer, an Opportunity or an Additional Threat? [PDF]
Zoń A, Bednarek IA.
europepmc +1 more source
Genomic Landscape Analysis of Canine Pulmonary Adenocarcinoma Reveals Candidate Targetable Gene Fusions. [PDF]
Sakthikumar S +10 more
europepmc +1 more source
Related searches:
Development of a degrader against oncogenic fusion protein FGFR3-TACC3
Bioorganic & Medicinal Chemistry Letters, 2022Fibroblast growth factor receptor 3-transforming acidic coiled-coil containing protein 3 (FGFR3-TACC3), which has been identified in many cancers such as glioblastoma and bladder cancer, is a potent oncogenic fusion protein that induces constitutive activation of FGFR signaling, resulting in uncontrolled cell proliferation.
Norihito, Shibata +3 more
openaire +2 more sources
A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences [PDF]
A biologically active complementary DNA clone of a transforming gene present in a human colon carcinoma contains gene sequences of both tropomyosin and a previously unknown protein tyrosine kinase. The predicted protein (641 amino acids) encoded by this oncogene seems to have been formed by a somatic rearrangement that replaced the extracellular domain
Dionisio Martin-Zanca +2 more
exaly +4 more sources
Pediatric Acute Megakaryoblastic Leukemia: Multitasking Fusion Proteins and Oncogenic Cooperations
Trends in Cancer, 2017Pediatric leukemia presents specific clinical and genetic features from adult leukemia but the underpinning mechanisms of transformation are still unclear. Acute megakaryoblastic leukemia (AMKL) is the malignant accumulation of progenitors of the megakaryocyte lineage that normally produce blood platelets. AMKL is diagnosed de novo, in patients showing
Cécile K, Lopez +4 more
openaire +2 more sources
The immune response to oncogenic fusion proteins
2001Chromosomal translocations represent somatically acquired cytogenetic mutations. When chromosomal breaks occur within exons of two different genes, the consequence of chromosomal translocation is the creation of a new fusion gene encoding for a chimeric protein.
Lorena Passoni +1 more
openaire +1 more source
About 15% of intrahepatic cholangiocarcinomas (iCCAs) express fibroblast growth factor receptor 2 (FGFR2) fusion proteins (FFs), usually alongside mutational inactivation of TP53, CDKN2A or BAP1. In FFs, FGFR2 residues 1-768 fuse to sequences encoded by a diverse array of partner genes (>60) causing oncogenic FF activation. While FGFR-specific tyrosine
Giulia Cristinziano +18 more
openaire +4 more sources

